Company news

ImmuneOnco Announced That “X-TANK” Trademark Application Has Been Approved

2016-12-21 0:00:00Click:673

     On December 21 of 2016, ImmuneOnco Biopharmaceuticals Co., Ltd., an emerging biotech company fully focusing on discovery and development of tumor immunotherapy, announced that, the first trademark, X-TANKTM, has been granted to be valid through December 21 of 2016 to December 20 of 2026 by The Trademark Office of The State Administration For Industry & Commerce of the People’s Republic of China.

     In “X-TANKTM”, “X” represents disease target,“TANK” stands for “Target-Activated NK”.